Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab vs Rabbit ATG/Cyclosporine in Refractory Severe Aplastic Anemia
NCT00065260Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Nov 2003
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in aplastic anemia, sponsored by National Heart, Lung, and Blood Institute. Started Nov 2003; status: completed.
02
Drugs
alemtuzumab
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT00065260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065260.